A step closer to Extreme Drug Resistance (XDR) in gram-negative bacilli

David L. Paterson; Yohei Doi

doi:10.1086/522287

A step closer to Extreme Drug Resistance (XDR) in gram-negative bacilli

David L. Paterson
, Yohei Doi

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1179-1181
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	45
Issue number	9
DOIs	https://doi.org/10.1086/522287
Publication status	Published - 2007
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/522287

Cite this

@article{18e3272c33354662816f7cff0ad438d9,

title = "A step closer to Extreme Drug Resistance (XDR) in gram-negative bacilli",

author = "Paterson, \{David L.\} and Yohei Doi",

note = "Funding Information: Potential conflicts of interest. D.L.P. has received research funding from AstraZeneca and Elan; has received consulting fees from Astra-Zeneca, Acureon, Protez, and Merck; and is on the speakers{\textquoteright} bureau for Elan, AstraZeneca, and Merck. Y.D.: no conflicts.",

year = "2007",

doi = "10.1086/522287",

language = "English",

volume = "45",

pages = "1179--1181",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - A step closer to Extreme Drug Resistance (XDR) in gram-negative bacilli

AU - Paterson, David L.

AU - Doi, Yohei

N1 - Funding Information: Potential conflicts of interest. D.L.P. has received research funding from AstraZeneca and Elan; has received consulting fees from Astra-Zeneca, Acureon, Protez, and Merck; and is on the speakers’ bureau for Elan, AstraZeneca, and Merck. Y.D.: no conflicts.

PY - 2007

Y1 - 2007

UR - https://www.scopus.com/pages/publications/35348821803

UR - https://www.scopus.com/pages/publications/35348821803#tab=citedBy

U2 - 10.1086/522287

DO - 10.1086/522287

M3 - Comment/debate

C2 - 17918079

AN - SCOPUS:35348821803

SN - 1058-4838

VL - 45

SP - 1179

EP - 1181

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -

A step closer to Extreme Drug Resistance (XDR) in gram-negative bacilli

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this